Application 090364
- Type
- ANDA
- Sponsor
- WATSON LABS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE | CAPSULE;ORAL | EQ 5MG BASE;40MG | No | No |
| 002 | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE | CAPSULE;ORAL | EQ 10MG BASE;40MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0591-3761 | Amlodipine and Benazepril Hydrochloride | Amlodipine and Benazepril Hydrochloride | Actavis Pharma, Inc. | ANDA | Current |
| 0591-3762 | Amlodipine and Benazepril Hydrochloride | Amlodipine and Benazepril Hydrochloride | Actavis Pharma, Inc. | ANDA | Current |
| 50090-3404 | Amlodipine and Benazepril Hydrochloride | Amlodipine and Benazepril Hydrochloride | A-S Medication Solutions | ANDA | Current |
| 63187-370 | Amlodipine Besylate and Benazepril Hydrochloride | Amlodipine Besylate and Benazepril Hydrochloride | Proficient Rx LP | ANDA | Current |